cocaine has been researched along with exenatide in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Egecioglu, E; Engel, JA; Jerlhag, E | 1 |
| Fink-Jensen, A; Galli, A; Graham, DL; Reddy, IA; Stanwood, GD; Sørensen, G; Weikop, P; Wortwein, G | 1 |
| De Jonghe, BC; Guercio, LA; Hayes, MR; Ige, KY; Maurer, JJ; Mietlicki-Baase, EG; Olivos, DR; Reiner, DJ; Schmidt, HD; Van Nest, DS; Wimmer, ME; Zimmer, DJ | 1 |
| Bering, T; Bluett, RJ; Erreger, K; Fink-Jensen, A; Galli, A; Graham, D; Hackett, TA; Osses, N; Patel, S; Pino, JA; Reddy, IA; Reyes, JG; Stanwood, GD; Sørensen, G; Torres, GE; Valle, C; Weikop, P; Wortwein, G | 1 |
| Fortin, SM; Roitman, MF | 1 |
| Hernandez, NS; O'Donovan, B; Ortinski, PI; Schmidt, HD | 1 |
| Christopher Pierce, R; Hernandez, NS; Mace, K; Merkel, R; Ragnini, K; Rich, MT; Schmidt, HD; Weir, VR; Zhang, Y | 1 |
| Angarita, GA; Costeines, JL; Jastreboff, AM; Malison, RT; Matuskey, D; Pittman, B; Potenza, MN; Schmidt, HD | 1 |
| Colvin, KJ; Currie, PJ; Dickinson, MB; Engel, L; Fimmel, AI; Halperin, MC; Holland, JG; Kanter, MJ; Killen, HS | 1 |
1 trial(s) available for cocaine and exenatide
| Article | Year |
|---|---|
Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder.
Topics: Adult; Cocaine; Cocaine-Related Disorders; Cross-Over Studies; Double-Blind Method; Exenatide; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Insulin; Islet Amyloid Polypeptide; Male; Middle Aged; Self Administration; Treatment Outcome | 2021 |
8 other study(ies) available for cocaine and exenatide
| Article | Year |
|---|---|
The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Liraglutide; Male; Mice; Motor Activity; Peptides; Receptors, Glucagon; Venoms | 2013 |
The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice.
Topics: Analysis of Variance; Animals; Benzazepines; Cocaine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Exenatide; Exploratory Behavior; Gene Expression Regulation; Hyperkinesis; Hypoglycemic Agents; Male; Mice; Microdialysis; Motor Activity; Peptides; Proto-Oncogene Proteins c-fos; Self Administration; Time Factors; Venoms | 2015 |
Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine.
Topics: Anesthetics, Local; Animals; Anti-Inflammatory Agents; Cocaine; Conditioning, Operant; Corticosterone; Exenatide; Fourth Ventricle; Glucagon-Like Peptide-1 Receptor; Green Fluorescent Proteins; Hypoglycemic Agents; Male; Neurons; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; RNA, Small Interfering; Self Administration; Venoms; Ventral Tegmental Area | 2016 |
Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Endocannabinoids; Exenatide; Glucagon-Like Peptide-1 Receptor; Glycerides; Homeostasis; Incretins; Mice; Microdialysis; Peptides; Proto-Oncogene Proteins c-fos; Septal Nuclei; Venoms | 2016 |
Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core.
Topics: Analysis of Variance; Animals; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Electrolysis; Exenatide; Glucagon-Like Peptide-2 Receptor; Hypoglycemic Agents; Male; Nucleus Accumbens; Peptides; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Venoms | 2017 |
Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats.
Topics: Animals; Cocaine; Conditioning, Operant; Dopamine Uptake Inhibitors; Drug-Seeking Behavior; Exenatide; Extinction, Psychological; Glucagon-Like Peptide-1 Receptor; Male; Neurons; Nucleus Accumbens; Rats, Sprague-Dawley | 2019 |
GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA.
Topics: Animals; Cocaine; Cocaine-Related Disorders; Exenatide; GABAergic Neurons; Glucagon-Like Peptide-1 Receptor; Rats; Rats, Sprague-Dawley; Ventral Tegmental Area | 2021 |
Differential effects of intra-ventral tegmental area ghrelin and glucagon-like peptide-1 on the stimulatory action of D-amphetamine and cocaine-induced ethanol intake in male Sprague Dawley rats.
Topics: Alcohol Drinking; Animals; Behavior, Animal; Central Nervous System Depressants; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Ethanol; Exenatide; Ghrelin; Glucagon-Like Peptide 1; Incretins; Male; Rats; Rats, Sprague-Dawley; Ventral Tegmental Area | 2022 |